Medicare's new $50 weight-loss drug program: Who qualifies and what are the concerns? - Reuters
Medicare's new $50 weight-loss drug program: Who qualifies and what are the concerns? Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxPRHlUdFBUSFQxSHlRYlV3S1ZscXBYNnZRS1ZMWTRoaHktU0hZNTNLMHoyZ3hqa3VQQ182dm5Eb0stS0htMF9fcFpOeXFTdlFuM081Y3EtWWlTdWFqdDBOdW9Qb1k2eWRTU0xiOVEwYmgyVEtUb3RkamdHUWhFeUE2d190Z3V3UmpTVF85UWs5SXRnMS05MUlGNXhkQW5MTC1hSzNSc01YdnJyY01XYVhJcXlpVC1DRjl6d25VZkVFTThRMWRq?oc=5" target="_blank">Medicare's new $50 weight-loss drug program: Who qualifies and what are the concerns?</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
More US employers to drop weight-loss drugs in 2027, as healthcare costs increase - Reuters
More US employers to drop weight-loss drugs in 2027, as healthcare costs increase Reuters
August 25, 2026 at 03:46 PMEli Lilly launches oral weight-loss pill Foundayo in UK - Reuters
Eli Lilly launches oral weight-loss pill Foundayo in UK Reuters
August 23, 2026 at 11:07 PMRevolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
August 26, 2026 at 06:18 PMChina's drug regulator accepts Novo Nordisk's application for oral Wegovy - Reuters
China's drug regulator accepts Novo Nordisk's application for oral Wegovy Reuters
August 27, 2026 at 03:47 AMWalmart settles US government's opioid lawsuit, which sought billions, for $50 million - Reuters
Walmart settles US government's opioid lawsuit, which sought billions, for $50 million Reuters
August 28, 2026 at 10:29 PMUS FDA approves Roivant-Priovant's skin and muscle disease drug - Reuters
US FDA approves Roivant-Priovant's skin and muscle disease drug Reuters
August 27, 2026 at 10:42 PM